Table 1 Model parameter values

Population size

0-2

63,025

2006 Census [42]

3-4

42,260

5-17

322,670

18-24

203,500

25-54

975,875

55-64

237,795

≥65

271,455

Total

2,116,580

Latent period (days)

All

3 (2-4)

Tuite et al. 2010 [22]

Initial asymptomatic infectious period (in all infected individuals) (days)

All

1

Liao et al. 2010 [43]

Total duration of infectiousness (days)

All

7 (5-7)

Tuite et al. 2010 [22]; De Serres [44]

Basic Reproduction number (R ₀)

All

1.4 (1.2-1.8)

Pourbohloul et al. 2009 [27]

Proportion of population with pre-existing immunity

≥55

0.5

Centers for Disease Control and Prevention 2009 [13]; Fisman et al. 2009 [6]

Vaccine efficacy

All

0.9 (0.5-1)

Product Monograph Arepanrix(tm) H1N1 [45]; Waddington et al., 2010 [46]

Proportion of infected individuals who self-isolate

All

0.1 (0.1-0.6)

Assumption

Mortality (per 100,000 infections)

0-2

30

Donaldson et al. 2009 [47]

2-4

27

5-17

11

18-24

12

25-54

30

55-64

65

≥65

980